The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(tert-butyl)phenyl)(4-(6-methyl-2-(pyrrolidin-1-yl)pyrimidin-4-yl)piperazin-1-yl)methanone ID: ALA5270898
Chembl Id: CHEMBL5270898
Max Phase: Preclinical
Molecular Formula: C24H33N5O
Molecular Weight: 407.56
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(N2CCN(C(=O)c3ccc(C(C)(C)C)cc3)CC2)nc(N2CCCC2)n1
Standard InChI: InChI=1S/C24H33N5O/c1-18-17-21(26-23(25-18)29-11-5-6-12-29)27-13-15-28(16-14-27)22(30)19-7-9-20(10-8-19)24(2,3)4/h7-10,17H,5-6,11-16H2,1-4H3
Standard InChI Key: QJZSBJRVAIZDFO-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.56Molecular Weight (Monoisotopic): 407.2685AlogP: 3.65#Rotatable Bonds: 3Polar Surface Area: 52.57Molecular Species: NEUTRALHBA: 5HBD: 0#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 7.63CX LogP: 4.55CX LogD: 4.13Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.78Np Likeness Score: -1.84
References 1. Hoshikawa T, Watanabe T, Kotake M, Tiberghien N, Woo CK, Lewis S, Briston T, Koglin M, Staddon JM, Powney B, Schapira AHV, Takle AK.. (2023) Identification of pyrimidinyl piperazines as non-iminosugar glucocerebrosidase (GCase) pharmacological chaperones., 81 [PMID:36640928 ] [10.1016/j.bmcl.2023.129130 ]